We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
+$1.5B
Cap. Flow
+$262M
Cap. Flow %
0.92%
Top 10 Hldgs %
43.01%
Holding
291
New
10
Increased
102
Reduced
100
Closed
10

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.8M
2
MSFT icon
Microsoft
MSFT
+$65M
3
AAPL icon
Apple
AAPL
+$45M
4
AMZN icon
Amazon
AMZN
+$42.8M
5
PM icon
Philip Morris
PM
+$40.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$56.2M
2
META icon
Meta Platforms (Facebook)
META
+$38.9M
3
AXP icon
American Express
AXP
+$32.9M
4
MS icon
Morgan Stanley
MS
+$32.6M
5
PG icon
Procter & Gamble
PG
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 23.05%
2 Consumer Staples 18.27%
3 Financials 17.61%
4 Energy 12.56%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
26
Mondelez International
MDLZ
$79.5B
$367M 1.29%
5,270,721
-220,566
-4% -$14.6M
MRK icon
27
Merck
MRK
$322B
$351M 1.23%
3,300,376
-131,058
-4% -$14.1M
EL icon
28
Estee Lauder
EL
$30.4B
$338M 1.18%
1,372,731
+44,830
+3% +$11.4M
ASML icon
29
ASML
ASML
$626B
$337M 1.18%
494,436
+2,092
+0.4% +$1.34M
ABBV icon
30
AbbVie
ABBV
$443B
$331M 1.16%
2,074,103
+53,400
+3% +$8.16M
JNJ icon
31
Johnson & Johnson
JNJ
$618B
$316M 1.1%
2,036,268
-348,190
-15% -$56.2M
CP icon
32
Canadian Pacific Kansas City
CP
$78.1B
$294M 1.03%
3,818,628
+190,973
+5% +$14.7M
CMCSA icon
33
Comcast
CMCSA
$85B
$286M 1%
7,534,381
+108,316
+1% +$4.1M
BNY
34
Bank of New York Mellon
BNY
$106B
$276M 0.97%
6,076,999
-647,520
-10% -$31.4M
MA icon
35
Mastercard
MA
$502B
$269M 0.94%
740,221
-13,532
-2% -$4.92M
MS icon
36
Morgan Stanley
MS
$331B
$269M 0.94%
3,060,806
-349,577
-10% -$32.6M
ADP icon
37
Automatic Data Processing
ADP
$106B
$230M 0.81%
1,034,296
+54,657
+6% +$12.3M
PGR icon
38
Progressive
PGR
$123B
$228M 0.8%
1,594,785
-13,807
-0.9% -$1.9M
ICE icon
39
Intercontinental Exchange
ICE
$85.6B
$225M 0.79%
2,162,106
-98,675
-4% -$10.3M
CB icon
40
Chubb
CB
$135B
$220M 0.77%
1,132,535
-99,866
-8% -$21M
RTX icon
41
RTX Corp
RTX
$290B
$219M 0.77%
2,233,447
+126,060
+6% +$12.4M
INTU icon
42
Intuit
INTU
$86.5B
$204M 0.71%
457,477
+5,230
+1% +$2.15M
BRK.A icon
43
Berkshire Hathaway Class A
BRK.A
$1.1T
$203M 0.71%
435
+53
+14% +$24.7M
MAR icon
44
Marriott International
MAR
$98.3B
$197M 0.69%
1,186,019
-5,683
-0.5% -$947K
ISRG icon
45
Intuitive Surgical
ISRG
$127B
$186M 0.65%
728,856
-8,122
-1% -$2M
ADBE icon
46
Adobe
ADBE
$99.5B
$160M 0.56%
414,856
+14,246
+4% +$5.06M
NKE icon
47
Nike
NKE
$61.9B
$159M 0.56%
1,296,086
-6,070
-0.5% -$746K
LIN icon
48
Linde
LIN
$221B
$141M 0.49%
395,996
+20,031
+5% +$6.71M
COP icon
49
ConocoPhillips
COP
$147B
$137M 0.48%
1,381,075
+129,822
+10% +$14.2M
SHW icon
50
Sherwin-Williams
SHW
$82.7B
$136M 0.47%
602,926
+6,670
+1% +$1.53M
1
2
3 4 5

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, up 5.6% from $27.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2023 filing shows 10 new, 102 increased, 100 reduced and 10 closed positions. Its largest new stake was MSCI: 9,600 shares worth $5.37M. The largest sale was Johnson & Johnson, an estimated $56.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.

  • Fayez Sarofim & Co's largest Q1 2023 buy was MSCI: 9,600 shares worth $5.37M.
  • Fayez Sarofim & Co added most to AstraZeneca in Q1 2023, an estimated $67.8M increase.
  • Fayez Sarofim & Co's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $56.2M.
  • Fayez Sarofim & Co fully exited Cohen & Steers in Q1 2023, selling an estimated $3.23M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $28.6B portfolio in Q1 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 10 in Q1 2023.
  • Fayez Sarofim & Co's portfolio value rose 5.6% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2023, filed 11 May 2023.